Tumor necrosis factor-α and interferon-γ induce expression of functional Fas ligand on HT29 and MCF7 adenocarcinoma cells

被引:24
作者
Naujokat, C
Sezer, O
Possinger, K
机构
[1] Humboldt Univ, Klinikum Charite, Fak Med, Dept Internal Med 2, D-10098 Berlin, Germany
[2] Univ Heidelberg, Inst Immunol, D-69120 Heidelberg, Germany
关键词
Fas ligand; Fas; TNF-alpha; IFN-gamma; apoptosis;
D O I
10.1006/bbrc.1999.1500
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor cells develop diverse mechanisms to escape from immune surveillance, including expression of Fas ligand (Fast), a 40-kDa type II transmembrane protein that mediates apoptosis by binding to its cognate receptor Fas (APO-1/CD95). Upon activation, T lymphocytes and natural killer (NK) cells express Fas and thus become sensitive to Fast-mediated apoptosis. Here we show that tumor necrosis factor-alpha (TNF-alpha) in addition to interferon-gamma (IFN-gamma) induces cell surface expression of functional Fast in human HT29 colon and MCF7 breast adenocarcinoma cells that constitutively lack cell surface expression of Fast. These cells, expressing Fast, are capable of inducing apoptosis in Fas-positive Jurkat T cells mediated by plasma membrane-bound Fast and soluble forms of Fast, By contrast, mutational deletion of Fas cell surface expression as web as inhibition of caspase family proteases involved in Fas signaling and monoclonal antibodies neutralizing Fast protect Jurkat T cells from apoptosis caused by the Fast-expressing HT29 or MCF7 cells. These results demonstrate that TNF-alpha and IFN-gamma induce expression of functional Fast in adenocarcinoma cells which thereby can kill T lymphocytes by the FasL/Fas pathway. (C) 1999 Academic Press.
引用
收藏
页码:813 / 819
页数:7
相关论文
共 51 条
[1]   FAS LIGAND MEDIATES ACTIVATION-INDUCED CELL-DEATH IN HUMAN T-LYMPHOCYTES [J].
ALDERSON, MR ;
TOUGH, TW ;
DAVISSMITH, T ;
BRADDY, S ;
FALK, B ;
SCHOOLEY, KA ;
GOODWIN, RG ;
SMITH, CA ;
RAMSDELL, F ;
LYNCH, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) :71-77
[2]   Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors [J].
Armstrong, RC ;
Aja, T ;
Xiang, JL ;
Gaur, S ;
Krebs, JF ;
Hoang, K ;
Bai, X ;
Korsmeyer, J ;
Karanewsky, DS ;
Fritz, LC ;
Tomaselli, KJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16850-16855
[3]  
Arnold R, 1999, J IMMUNOL, V162, P7140
[4]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[5]   A ROLE FOR CD95 LIGAND IN PREVENTING GRAFT-REJECTION [J].
BELLGRAU, D ;
GOLD, D ;
SELAWRY, H ;
MOORE, J ;
FRANZUSOFF, A ;
DUKE, RC .
NATURE, 1995, 377 (6550) :630-632
[6]   Induction of apoptosis by IFNγ in human neuroblastoma cell lines through the CD95/CD95L autocrine circuit [J].
Bernassola, F ;
Scheuerpflug, C ;
Herr, I ;
Krammer, PH ;
Debatin, KM ;
Melino, G .
CELL DEATH AND DIFFERENTIATION, 1999, 6 (07) :652-660
[7]  
Choi C, 1999, J IMMUNOL, V162, P1889
[8]   Simultaneous production of T helper-1-like cytokines and cytolytic activity by tumor-specific T cells in ovarian and breast cancer [J].
Goedegebuure, PS ;
Douville, CC ;
Doherty, JM ;
Linehan, DC ;
Lee, KY ;
Ganguly, EK ;
Eberlein, TJ .
CELLULAR IMMUNOLOGY, 1997, 175 (02) :150-156
[9]  
Gratas C, 1998, CANCER RES, V58, P2057
[10]   Apoptotic pathways: The roads to ruin [J].
Green, DR .
CELL, 1998, 94 (06) :695-698